Taisho Acquires BMS Indonesia, OTC Pharmaceutical Trademarks, Assets
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal gives Taisho immediate access to the Asia-Pacific OTC drug market as the second Japanese pharma to acquire a foreign OTC manufacturer after Daiichi-Sankyo's acquisition of India's Ranbaxy.